[
  {
    "ts": null,
    "headline": "3 Drug Stocks to Buy at a Discount",
    "summary": "The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap industry giants to consider.",
    "url": "https://finnhub.io/api/news?id=9fcdcc39ce0addd277b2951b739d1aac0fe758a8e69a9b299ea726657eeba350",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767820800,
      "headline": "3 Drug Stocks to Buy at a Discount",
      "id": 138033031,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap industry giants to consider.",
      "url": "https://finnhub.io/api/news?id=9fcdcc39ce0addd277b2951b739d1aac0fe758a8e69a9b299ea726657eeba350"
    }
  },
  {
    "ts": null,
    "headline": "This Could Be Key to Pfizer's Turnaround in 2026",
    "summary": "Pfizer's been focusing on a hot area of healthcare recently: GLP-1 drugs.",
    "url": "https://finnhub.io/api/news?id=a235be89607242e61a6639ac03fb2a5b7a0c389df4c8ff4ab4ff246e2e9b089b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767810900,
      "headline": "This Could Be Key to Pfizer's Turnaround in 2026",
      "id": 138033382,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's been focusing on a hot area of healthcare recently: GLP-1 drugs.",
      "url": "https://finnhub.io/api/news?id=a235be89607242e61a6639ac03fb2a5b7a0c389df4c8ff4ab4ff246e2e9b089b"
    }
  },
  {
    "ts": null,
    "headline": "What BioNTech (BNTX)'s 90%+ COVID Vaccine Efficacy Signal Means For Shareholders",
    "summary": "Pfizer and BioNTech previously announced that their jointly developed COVID-19 vaccine showed over 90% effectiveness in preventing infection based on initial trial data, although scientists highlighted unanswered questions about long-term protection and impact on severe disease. This early efficacy signal positioned BioNTech’s mRNA platform at the center of the global pandemic response, while simultaneously underscoring the scientific and regulatory uncertainties that still surround...",
    "url": "https://finnhub.io/api/news?id=662f7a5ac4b8bb508032b1fbf5d06e1b333808a41edf1bb2911bd1318d7f518c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767809402,
      "headline": "What BioNTech (BNTX)'s 90%+ COVID Vaccine Efficacy Signal Means For Shareholders",
      "id": 138033383,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer and BioNTech previously announced that their jointly developed COVID-19 vaccine showed over 90% effectiveness in preventing infection based on initial trial data, although scientists highlighted unanswered questions about long-term protection and impact on severe disease. This early efficacy signal positioned BioNTech’s mRNA platform at the center of the global pandemic response, while simultaneously underscoring the scientific and regulatory uncertainties that still surround...",
      "url": "https://finnhub.io/api/news?id=662f7a5ac4b8bb508032b1fbf5d06e1b333808a41edf1bb2911bd1318d7f518c"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline",
    "summary": "AMGN's $840M buyout of Dark Blue Therapeutics adds a preclinical AML degrader, bolstering its oncology pipeline.",
    "url": "https://finnhub.io/api/news?id=f6b040665acd6d6b6a6c4a27817b163bd750a5f3f4f7c579932d640034bc74e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767792780,
      "headline": "Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline",
      "id": 138027089,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "AMGN's $840M buyout of Dark Blue Therapeutics adds a preclinical AML degrader, bolstering its oncology pipeline.",
      "url": "https://finnhub.io/api/news?id=f6b040665acd6d6b6a6c4a27817b163bd750a5f3f4f7c579932d640034bc74e2"
    }
  },
  {
    "ts": null,
    "headline": "Update: Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents",
    "summary": "(Updates with BioNTech response in the sixth paragraph.) Bayer's Monsanto unit filed patent infri",
    "url": "https://finnhub.io/api/news?id=e5c77a2fe7091981dd53185666bec5831fb972f3f299051ef9ee72dd1795f29a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767780436,
      "headline": "Update: Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents",
      "id": 138025813,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "(Updates with BioNTech response in the sixth paragraph.) Bayer's Monsanto unit filed patent infri",
      "url": "https://finnhub.io/api/news?id=e5c77a2fe7091981dd53185666bec5831fb972f3f299051ef9ee72dd1795f29a"
    }
  },
  {
    "ts": null,
    "headline": "Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents",
    "summary": "Bayer's Monsanto unit filed patent infringement lawsuits Tuesday against COVID-19 vaccine makers Pfi",
    "url": "https://finnhub.io/api/news?id=c93fa9c0158f85e0cd9a915d7eb39afb2c20ee091a54a1d292c654d0624fc0a3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767776014,
      "headline": "Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents",
      "id": 138025815,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Bayer's Monsanto unit filed patent infringement lawsuits Tuesday against COVID-19 vaccine makers Pfi",
      "url": "https://finnhub.io/api/news?id=c93fa9c0158f85e0cd9a915d7eb39afb2c20ee091a54a1d292c654d0624fc0a3"
    }
  },
  {
    "ts": null,
    "headline": "Quant Q&A With Steven Cress",
    "summary": "Seeking Alpha's Head of Quant, Steven Cress, answers your questions!",
    "url": "https://finnhub.io/api/news?id=b803d76c99d6e4c8d5780b1be6003950f35a55319b3ccd006ca515631dfc6e08",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767769200,
      "headline": "Quant Q&A With Steven Cress",
      "id": 138025654,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1097346792/image_1097346792.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Seeking Alpha's Head of Quant, Steven Cress, answers your questions!",
      "url": "https://finnhub.io/api/news?id=b803d76c99d6e4c8d5780b1be6003950f35a55319b3ccd006ca515631dfc6e08"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma race to snap up biotech assets as $170 billion patent cliff looms",
    "summary": "Companies are facing a situation where they need to fill their pipelines, but also navigate a competitive environment for the best assets.",
    "url": "https://finnhub.io/api/news?id=a0c504f9e512dfd1f9c4c0c403aa8efad6e2dd4ab308b1791cfebe567d1454ed",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767753071,
      "headline": "Big Pharma race to snap up biotech assets as $170 billion patent cliff looms",
      "id": 138028004,
      "image": "https://image.cnbcfm.com/api/v1/image/108248856-1767718931887-gettyimages-1417392226-_x3m1126.jpeg?v=1767718937&w=1920&h=1080",
      "related": "PFE",
      "source": "CNBC",
      "summary": "Companies are facing a situation where they need to fill their pipelines, but also navigate a competitive environment for the best assets.",
      "url": "https://finnhub.io/api/news?id=a0c504f9e512dfd1f9c4c0c403aa8efad6e2dd4ab308b1791cfebe567d1454ed"
    }
  },
  {
    "ts": null,
    "headline": "European defense stocks rise for 4th day as Denmark moves to rearm Greenland",
    "summary": "European stocks closed in negative territory on Wednesday as regional market jitters grew over U.S. President Donald Trump's threat to annex Greenland.",
    "url": "https://finnhub.io/api/news?id=20f22ec09b5e56fd02e1c85a4c3f6b402b54511399e7212268db55f1321159bf",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767748432,
      "headline": "European defense stocks rise for 4th day as Denmark moves to rearm Greenland",
      "id": 138028179,
      "image": "https://image.cnbcfm.com/api/v1/image/108228069-1763548663378-gettyimages-2203984679-AFP_36ZR9XP.jpeg?v=1767699514&w=1920&h=1080",
      "related": "PFE",
      "source": "CNBC",
      "summary": "European stocks closed in negative territory on Wednesday as regional market jitters grew over U.S. President Donald Trump's threat to annex Greenland. ",
      "url": "https://finnhub.io/api/news?id=20f22ec09b5e56fd02e1c85a4c3f6b402b54511399e7212268db55f1321159bf"
    }
  }
]